Brett K. Haumann

Sources

The numbers on this page point here. Each one links to the record it came from.

1. 1
   SEC EDGARTheravance Biopharma, Inc., VP-Clinical Develop.
2. 2
   SEC EDGARAimmune Therapeutics (United Kingdom), Board member